Ascend Wellness Holdings (AAWH) Receivables - Net (2020 - 2026)
Ascend Wellness Holdings' (AAWH) quarterly Receivables - Net came in at $26.4 million in Q1 2026, down 28.04% year-on-year from $36.7 million in Q1 2025, and down 2.23% quarter-over-quarter from $27.0 million in Q4 2025.
Ascend Wellness Holdings (AAWH) Receivables - Net (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Receivables - Net history runs 7 years deep, the most recent figure standing at $26.4 million for Q1 2026.
- On a quarterly basis, Receivables - Net fell 28.04% year-over-year to $26.4 million in Q1 2026; TTM through Mar 2026 was $26.4 million, a 28.04% decrease from a year earlier, with the FY2025 full-year figure at $27.0 million, down 26.05% from the prior year.
- Receivables - Net fell to $26.4 million in Q1 2026 per AAWH's latest filing, from $27.0 million in the prior quarter.
- Across five years, Receivables - Net topped out at $38.8 million in Q3 2024 and bottomed at $9.2 million in Q2 2022.
- The 5-year median for Receivables - Net is $27.0 million (2025), against an average of $25.8 million.
- Across the five-year window, Receivables - Net jumped 141.21% in 2023 and declined 28.04% in 2026, its largest moves.
- Year by year, Receivables - Net stood at $14.1 million in 2022, then jumped by 100.68% to $28.3 million in 2023, then increased by 29.13% to $36.5 million in 2024, then retreated by 26.05% to $27.0 million in 2025, then fell by 2.23% to $26.4 million in 2026.
- Per Business Quant, the three latest AAWH Receivables - Net figures stand at $26.4 million (Q1 2026), $27.0 million (Q4 2025), and $28.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Ascend Wellness Holdings | 83.00 Mn | 22.91 Mn | 44.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.42 Mn |
| Mar 31, 2026 | 26.42 Mn |
| Dec 31, 2025 | 27.02 Mn |
| Dec 31, 2025 | 27.02 Mn |
| Sep 30, 2025 | 28.85 Mn |
| Sep 30, 2025 | 28.85 Mn |
| Jun 30, 2025 | 30.64 Mn |
| Jun 30, 2025 | 30.64 Mn |
| Mar 31, 2025 | 36.72 Mn |
| Mar 31, 2025 | 36.72 Mn |
| Dec 31, 2024 | 36.54 Mn |
| Dec 31, 2024 | 36.54 Mn |
| Sep 30, 2024 | 38.78 Mn |
| Sep 30, 2024 | 38.78 Mn |
| Jun 30, 2024 | 35.31 Mn |
| Jun 30, 2024 | 35.31 Mn |
| Mar 31, 2024 | 35.90 Mn |
| Mar 31, 2024 | 35.90 Mn |
| Dec 31, 2023 | 28.30 Mn |
| Dec 31, 2023 | 28.30 Mn |